Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Gomez

Showing results (81-90 of 231) with videos related to

Pageof 24
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Cardiac ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapyJaden D Evans, Daniel R Gomez, Joe Y Chang, et al.
American Journal of Clinical Oncology|January 7, 2014
Treatment Modalities and Outcomes in Patients With Advanced Invasive Thymoma or Thymic Carcinoma: A Retrospective Multicenter StudyAnkit Modh, Andreas Rimner, Pamela K Allen, et al.
Clinical Lung Cancer|December 4, 2016
Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung CancerJay P Reddy, Chad Tang, Tina Shih, et al.
Cancer Medicine|May 11, 2018
Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancerJu Yang, Ting Xu, Daniel R Gomez, et al.
American Journal of Clinical Oncology|November 27, 2023
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung CancerChristian M Alvarez, Maureen Aliru, Bhavani S Gannavarapu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2021
Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLCAhsan Farooqi, Ethan B Ludmir, Kyle G Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung CancerPei Yang, Ting Xu, Daniel R Gomez, et al.
Seminars in Radiation Oncology|March 21, 2022
The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic DiseaseBill H Diplas, Patricia Mae G Santos, Armin Shahrokni, et al.
Annals of Surgical Oncology|February 4, 2017
Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data BaseTodd A Pezzi, Abdallah S R Mohamed, Clifton D Fuller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2019
Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancerNarek Shaverdian, Michael D Offin, Andreas Rimner, et al.
Pageof 24

Showing results (81-90 of 231) with videos related to

Sort By:
Pageof 24
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Cardiac ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapyJaden D Evans, Daniel R Gomez, Joe Y Chang, et al.
American Journal of Clinical Oncology|January 7, 2014
Treatment Modalities and Outcomes in Patients With Advanced Invasive Thymoma or Thymic Carcinoma: A Retrospective Multicenter StudyAnkit Modh, Andreas Rimner, Pamela K Allen, et al.
Clinical Lung Cancer|December 4, 2016
Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung CancerJay P Reddy, Chad Tang, Tina Shih, et al.
Cancer Medicine|May 11, 2018
Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancerJu Yang, Ting Xu, Daniel R Gomez, et al.
American Journal of Clinical Oncology|November 27, 2023
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung CancerChristian M Alvarez, Maureen Aliru, Bhavani S Gannavarapu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2021
Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLCAhsan Farooqi, Ethan B Ludmir, Kyle G Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung CancerPei Yang, Ting Xu, Daniel R Gomez, et al.
Seminars in Radiation Oncology|March 21, 2022
The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic DiseaseBill H Diplas, Patricia Mae G Santos, Armin Shahrokni, et al.
Annals of Surgical Oncology|February 4, 2017
Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data BaseTodd A Pezzi, Abdallah S R Mohamed, Clifton D Fuller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2019
Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancerNarek Shaverdian, Michael D Offin, Andreas Rimner, et al.
Pageof 24